Publications by authors named "Ubaldo Martin"

Claim this Profile
I
In vitro and clinical data demonstrate negligible risk of drug-drug interactions with opelconazole, a novel inhaled antifungal agent.
Lindsey M R Cass, John Ayrton, Roger J Brüggemann, Jerome Moore, Ubaldo Martin

J Antimicrob Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting response to benralizumab in patients with COPD: a plain language summary of publication of the GALATHEA and TERRANOVA studies.
Gerard J Criner, Dave Singh, Alberto Papi, Maria Jison, Natalya Makulova, Ubaldo J Martin

Ther Adv Respir Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multivariate Cluster Analyses to Characterize Asthma Heterogeneity and Benralizumab Responsiveness.
Xingnan Li, Paul Newbold, Rohit Katial, Ian Hirsch, Huashi Li, Ubaldo J Martin

J Allergy Clin Immunol Pract· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric Validation and Meaningful Change Thresholds of the New Nasal Polyposis Symptom Diary.
Vivian H Shih, Ashley F Slagle, Cristina Ivanescu, Giulio Flore, Oren Meyers, Ubaldo J Martin

Ann Otol Rhinol Laryngol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis.
Dave Singh, Gerard J Criner, Alvar Agustí, Mona Bafadhel, Johan Söderström, Ubaldo J Martin

Int J Chron Obstruct Pulmon Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study.
Andrew Menzies-Gow, Mark Gurnell, Liam G Heaney, Jonathan Corren, Elisabeth H Bel, Ubaldo J Martin

Eur Respir J· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring the patient experience of chronic rhinosinusitis with nasal polyposis: qualitative development of a novel symptom diary.
Sean O'Quinn, Vivian H Shih, Ubaldo J Martin, Oren Meyers, Patrick Crooks

Int Forum Allergy Rhinol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting TSLP in Asthma.
Jane R Parnes, Nestor A Molfino, Gene Colice, Ubaldo Martin, Jonathan Corren

J Asthma Allergy· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial.
Claus Bachert, Joseph K Han, Martin Y Desrosiers, Philippe Gevaert, Enrico Heffler, Ubaldo J Martin

J Allergy Clin Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study.
Andrew Menzies-Gow, Mark Gurnell, Liam G Heaney, Jonathan Corren, Elisabeth H Bel, Ubaldo J Martin

Lancet Respir Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatment.
William W Busse, Eugene R Bleecker, J Mark FitzGerald, Gary T Ferguson, Peter Barker, Ubaldo J Martin

J Allergy Clin Immunol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD.
Wilfried De Backer, Jan De Backer, Ilse Verlinden, Glenn Leemans, Cedric Van Holsbeke, Martin Jenkins, Ubaldo J Martin

Ther Adv Respir Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma.
Arnaud Bourdin, Dominick Shaw, Andrew Menzies-Gow, J Mark FitzGerald, Eugene R Bleecker, Ubaldo J Martin

J Asthma· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD.
Rongchang Chen, Nanshan Zhong, Hao-Yan Wang, Li Zhao, Xiaodong Mei, Ubaldo J Martin

Int J Chron Obstruct Pulmon Dis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies.
Fernando J Martinez, Klaus F Rabe, Brian J Lipworth, Samir Arora, Martin Jenkins, Ubaldo J Martin

Int J Chron Obstruct Pulmon Dis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of autoinjector with accessorized prefilled syringe for benralizumab pharmacokinetic exposure: AMES trial results.
Ubaldo J Martin, Rainard Fuhr, Pablo Forte, Peter Barker, Milton J Axley

J Asthma· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler delivered using co-suspension delivery technology in Japanese patients with moderate-to-very severe chronic obstructive pulmonary disease.
Yasuhiro Gon, Koichi Nishi, Kazuhiro Sato, Andrea Maes, Shahid Siddiqui, Ubaldo J Martin

Respir Investig· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease.
Dave Singh, Mona Bafadhel, Christopher E Brightling, Frank C Sciurba, Jeffrey L Curtis, Fernando J Martinez, Ubaldo J Martin

Am J Respir Crit Care Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood eosinophil count group shifts and kinetics in severe eosinophilic asthma.
Njira L Lugogo, James L Kreindler, Ubaldo J Martin, Bill Cook, Ian Hirsch

Ann Allergy Asthma Immunol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab.
David J Jackson, Stephanie Korn, Sameer K Mathur, Peter Barker, Venkata G Meka, Ubaldo J Martin

Drug Saf· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies.
Gerard J Criner, Bartolome R Celli, Dave Singh, Alvar Agusti, Alberto Papi, Ubaldo J Martin

Lancet Respir Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA).
Reynold A Panettieri, Tobias Welte, Kartik V Shenoy, Stephanie Korn, Margret Jandl, Ubaldo J Martin

J Asthma Allergy· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma.
J Mark FitzGerald, Eugene R Bleecker, Arnaud Bourdin, William W Busse, Gary T Ferguson, Ubaldo J Martin

J Asthma Allergy· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Use Autoinjector Functionality And Reliability For At-Home Administration Of Benralizumab For Patients With Severe Asthma: GRECO Trial Results.
Gary T Ferguson, Jeremy Cole, Magnus Aurivillius, Paul Roussel, Peter Barker, Ubaldo J Martin

J Asthma Allergy· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial.
Andrew Menzies-Gow, Jonathan Corren, Elisabeth H Bel, Jorge Maspero, Liam G Heaney, Ubaldo J Martin

ERJ Open Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis